Growth investing favours companies whose sales and earnings are growing faster than average. As a quantitative signal, growth is measured from past or expected changes in revenue, earnings or cash flow, and it is often treated as the opposite of value.
Typical growth measures
| Measure | Example |
|---|---|
| Sales growth | Revenue up 18% in the last year |
| Earnings growth | EPS growth over 3 to 5 years |
| Expected growth | Analyst forecasts of next year's earnings |
| Valuation-based | High price-to-earnings or price-to-sales, signalling growth expectations. See value investing |
An illustrative comparison
| Growth stock | Value stock | |
|---|---|---|
| Sales growth | 25% | 4% |
| P/E ratio | 45 | 12 |
| What investors pay for | Future growth | Current earnings |
The numbers are made up.
What research finds
- Lakonishok, Shleifer and Vishny (1994) argued that investors extrapolate past growth too far, so high-growth stocks have tended to disappoint on average and value stocks to beat them.
- Growth as a standalone factor has a weak record, since high growth is usually already reflected in the price.
- Growth works better when combined with quality and reasonable valuation, a combination sometimes called growth at a reasonable price.
- It overlaps with asset growth, which has had a negative relation with returns, and with momentum.
Cautions
Growth is cyclical and can dominate for many years, as in periods of falling interest rates. See factor timing and market regimes.
Frequently asked questions
What is growth investing?
It is an approach that favours companies with fast-growing sales and earnings, usually accepting higher valuations.
Is growth a factor like value or momentum?
It is used as a style, but as a standalone quantitative factor its evidence is weaker, because growth is largely priced in.
How is growth measured?
By past growth in sales, earnings or cash flow, analyst forecasts, or valuation ratios that signal growth expectations.
What is growth at a reasonable price?
A blend that looks for growing companies that are not excessively priced, often using quality and valuation measures together.